XML 29 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements Of Cash Flows (USD $)
3 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash Flows from Operating Activities:  
Net (loss)$ (789,649)$ (649,162)
Adjustments to reconcile net loss to cash provided by operating activities of continuing operations:  
Income from discontinued operations0(304,244)
Depreciation and amortization222,542240,182
Compensation expense related to stock options23,89839,359
(Income)/loss of Ocular Telehealth Management, LLC(699)22,638
Change in operating assets and liabilities:  
Accounts receivable, net1,168,881(356,135)
Inventory, net(90,888)(762,717)
Other current and long-term assets(60,473)53,060
Accounts payable, accrued expenses and other liabilities(433,084)640,266
Net cash (used in) provided by operating activities from continuing operations40,528(1,076,753)
Net cash provided by operating activities from discontinued operations 243,967
Net cash (used in) provided by operating activities40,528(832,786)
Cash Flows from Investing Activities:  
Investment in Ocular Telehealth Management, LLC0(24,000)
Purchase of fixed assets(6,927)(63,590)
Net cash used in investing activities from continuing operations(6,927)(87,590)
Cash Flows from Financing Activities:  
Proceeds from related-party note payable134,4880
Principal payments on long-term debt(88,555)(50,538)
Net cash provided by/(used in) financing activities from continuing operations45,933(50,538)
Effect of exchange rate changes on cash & cash equivalents(122,803)305,495
Net (decrease) in cash and cash equivalents(43,269)(665,419)
Cash and cash equivalents, beginning of period1,915,2143,342,422
Cash and cash equivalents, end of period1,871,9452,677,003
Supplemental Schedule of Cash Flow Information:  
Interest paid$ 82,491$ 590